Stephen Globus is a New York City venture capitalist who is third generation from a prominent banking family.
He was a founding shareholder of Genitope Corporation,[2] which is a San Francisco-area biotechnology company that designs custom treatments for cancer, including a vaccine to treat lymphoma.
Globus was founder and chairman of PlasmaCo[3][4] which developed color plasma television and sold[5] to Osaka-based Matsushita (Panasonic) in 1996.
His other ventures activities include key investment or managerial roles in Proscure (sold to Repligen[6]), ExSar,[7] Kimeragen which sold to a Paris-based company whose board Globus served on, Energy Research (Fuel Cell Energy),[8] Nematron,[9] and Tinsley Laboratories,[10] which developed the optic correction for Hubble Space Telescope now a division of the Dutch company ASML.
He is patron of the arts with associations such as Japan Society of New York and China Institute in America.